To investigate the expression status of these upregulated genes in prostate cancer BoM samples, we retrieved PRAD BoM scRNAseq data from the GEO database (GSE143791) and reconstructed a UMAP plot (Figure 7A) representing the distributions of 80,368 cells based on the annotations from the original publication (21). This evidence concerns the gene GRHL2 and prostate carcinoma.